研究关注：Regulators Should Rely on Peers’ GMP Audits to Cut Inspection Burden

## 事件概览

Duplicate GMP inspections are a major challenge for biopharmaceutical manufacturing companies. The IFMPA, urges regulators to rely on audits...

## 核心信息

Duplicate GMP inspections are a major challenge for biopharmaceutical manufacturing companies. The IFMPA, urges regulators to rely on audits carried out by peers to minimize the time drug firms spend not making medicines. The post Regulators Should Rely on Peers’ GMP Audits to Cut Inspection Burden appeared first on GEN - Genetic Engineering and Biotechnology News .

## 为什么值得关注

这条内容与 drug discovery 相关，可能影响科研选题、技术趋势判断或产业观察。BioDir 已根据来源、摘要长度、主题词和潜在影响给出 39 分的候选评分。

## 发布提示

发布前应核对原文链接、研究对象、样本规模、方法限制和结论边界。若来源为 bioRxiv 或 medRxiv，应明确标注其为预印本，尚未经过同行评议。